文献速递临床试验与 GCP真实世界研究与卫生经济

复杂急性阑尾炎阑尾切除术后抗生素疗程:48小时对比5天随机对照试验方案

Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-05-02

本研究为多中心随机对照试验方案,纳入8岁及以上复杂急性阑尾炎(坏疽性和/或穿孔性或伴脓肿)行阑尾切除术患者1066例,1:1随机分配至术后静脉抗生素48小时组或5天组。主要终点为术后90天内感染性并发症(腹腔脓肿和手术部位感染)与死亡的复合终点,非劣效界值7.5%(单侧α=0.025)。

要点

  • 复杂阑尾炎术后48小时静脉抗生素可能非劣于5天疗程。
  • 主要终点为90天内感染性并发症与死亡的复合终点。
  • 非劣效界值7.5%,单侧检验α=0.025。

核心结论

  • 该试验旨在验证复杂急性阑尾炎阑尾切除术后48小时抗生素方案是否非劣于5天标准疗程。
  • 若非劣效成立,可放弃术后较长疗程静脉抗生素并调整相关指南。

研究设计与样本

  • 随机对照试验方案,计划纳入1066例8岁及以上复杂急性阑尾炎行阑尾切除术患者,1:1随机分组。
  • 试验组为术后48小时静脉抗生素,对照组为术后5天静脉抗生素。
  • 主要分析包括符合方案分析和意向性分析。

主要发现

  • 原文为研究方案,未报告试验结果。

关键数值与推荐

  • 复杂阑尾炎定义为坏疽性和/或穿孔性阑尾炎或阑尾炎伴脓肿。
  • 主要终点为术后90天内感染性并发症(腹腔脓肿和手术部位感染)与死亡的复合终点。
  • 非劣效界值为主要终点率差7.5%,单侧检验α=0.025。
  • 排除免疫抑制或妊娠患者及对研究抗生素有禁忌者。

临床怎么用

  • 该方案为复杂阑尾炎术后抗生素疗程优化提供随机对照证据,结果可能影响指南推荐。

局限性

  • 原文为研究方案,尚未报告试验结果,无法评估疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute appendicitis is one of the most common indications for emergency surgery. In patients with a complex appendicitis, prolonged antibiotic prophylaxis is recommended after appendectomy. There is no consensus regarding the optimum duration of antibiotics. Guidelines propose 3 to 7 days of treatment, but shorter courses may be as effective in the prevention of infectious complications. At the same time, the global issue of increasing antimicrobial resistance urges for optimization of antibiotic strategies. The aim of this study is to determine whether a short course (48 h) of postoperative antibiotics is non-inferior to current standard practice of 5 days. METHODS: Patients of 8 years and older undergoing appendectomy for acute complex appendicitis - defined as a gangrenous and/or perforated appendicitis or appendicitis in presence of an abscess - are eligible for inclusion. Immunocompromised or pregnant patients are excluded, as well as patients with a contraindication to the study antibiotics. In total, 1066 patients will be randomly allocated in a 1:1 ratio to the experimental treatment arm (48 h of postoperative intravenously administered (IV) antibiotics) or the control arm (5 days of postoperative IV antibiotics). After discharge from the hospital, patients participate in a productivity-cost-questionnaire at 4 weeks and a standardized telephone follow-up at 90 days after appendectomy. The primary outcome is a composite endpoint of infectious complications, including intra-abdominal abscess (IAA) and surgical site infection (SSI), and mortality within 90 days after appendectomy. Secondary outcomes include IAA, SSI, restart of antibiotics, length of hospital stay (LOS), reoperation, percutaneous drainage, readmission rate, and cost-effectiveness. The non-inferiority margin for the difference in the primary endpoint rate is set at 7.5% (one-sided test at ɑ 0.025). Both per-protocol and intention-to-treat analyses will be performed. DISCUSSION: This trial will provide evidence on whether 48 h of postoperative antibiotics is non-inferior to a standard course of 5 days of antibiotics. If non-inferiority is established, longer intravenous administration following appendectomy for complex appendicitis can be abandoned, and guidelines need to be adjusted accordingly. TRIAL REGISTRATION: Dutch Trial Register, NTR6128 . Registered on 20 December 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van den Boom AL, de Wijkerslooth EML, van Rosmalen J, et al. Two versus five days of antibiotics after appendectomy for complex acute appendicitis (APPIC): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29720238. doi:10.1186/s13063-018-2629-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。